Zenas BioPharma, Inc. Net Fee Amt
Zenas BioPharma, Inc. (ZBIO) had Net Fee Amt of $2.72 thousand as of 2026-09-10, per its S-8 filed 2026-09-11.
Financial Statements › Notes
ffd:NetFeeAmt · last filed 2026-09-11
- 2026-09-10: Net Fee Amt $2.72K.
| Period end | Net Fee Amt |
|---|---|
| 2026-09-10 | $2.72K S-8 · filed 2026-09-11 |